China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …

Post Author

Editorialista

Send us your press release. China-underground.com helps clients reach all their key audiences – including industry professionals, decision-makers, journalists, researchers, and the public. Contact.

See author's posts